Clinical Efficacy and Safety of Artesimia annua-Sublingual Immunotherapy in Seasonal Allergic Rhinitis Patients Based on Different Intervention Time.

Jiayi Yang,Zhen Shen,Lifeng Liu,Wei Kang,Yuan Shao,Pengfei Zhang,Fang Quan

International archives of allergy and immunology（2022）

引用 5|浏览6

暂无评分

摘要

This study proved that A. annua-SLIT can provide equivalent efficacy and safety for SAR patients under the circumstance of accepting the pre-seasonal treatment of 8-9 or 12-13 weeks, regardless of monosensitization or polysensitization.

查看译文

关键词

Artemisia annua,Efficacy,Safety,Seasonal allergic rhinitis,Sublingual immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要